BC
VCYT icon

Bridgefront Capital’s Veracyte VCYT Stock Holding History

Bridgefront Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,785
Closed -$233K – 796
2025
Q3 		$233K Buy
+6,785
New +$195K 0.07% 476
2021
Q1 		– Sell
-8,006
Closed -$392K – 932
2020
Q4 		$392K Buy
+8,006
New +$371K 0.13% 280

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bridgefront Capital's VCYT Position: Q4 2025 in Review

Bridgefront Capital sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 6,785 shares — an estimated $233K sold.

Bridgefront Capital first reported a position in VCYT in Q4 2020 and held it in 2 quarters. The position peaked at $392K in Q4 2020. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Bridgefront Capital reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 6,785 Veracyte shares in Q4 2025, an estimated $233K.
  • Bridgefront Capital first reported a position in Veracyte in Q4 2020 and held it in 2 quarters.
  • Bridgefront Capital's Veracyte position peaked at $392K in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.